// App-Quantinova.ai

Mo1002 : In Non-Alcoholic Fatty Liver Disease, Differential Gene Expression for Phospholipid Metabolism Is Associated With Lower Hepatic Phosphatidylcholine to Phosphatidylethanolamine Ratio, but Not With Lower Choline Intake

Researchers

Presenter

  • Ian D. McGilvray

Principal Investigators

  • Elena Comelli

  • David W. Ma

  • Scott Fung

  • AnaLaura Guzman

  • Sandra E. Fischer

  • Johane P. Allard

Medical Centers

  • Department of Surgery, University of Toronto, Toronto, ON, Canada

  • Human Health and Nutritional Sciences, University of Guelph, Guelph, ON, Canada

  • Toronto General Hospital, University of Toronto, Toronto, ON, Canada

  • Medicine, Univ of Toronto, Toronto, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Nonalcoholic fatty liver disease

  • Fatty Liver Disease

  • Nonalcoholic steatohepatitis

Biomarkers

  • Cancer antigen 15-3

  • Choline

  • L-plastin

Drug/Treatment

  • LT 02

  • lipase

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved